An in vivo functional assay to characterize human STAT5B genetic variants during zebrafish development

ESTEFANIA LANDI; KARABATAS L; TOMÁS RODRIGUEZ GOMEZ; SALATINO LUCIA; PAULA SCAGLIA; RAMIREZ LAURA; KESELMAN ANA; DEBORA BRASLAVSKY; SANGUINETI N; PATRICIA A PENNISI; REY RODOLFO; BERGADA, I; DOMENE H; PLAZAS PAOLA; DOMENE SABINA

HUMAN MOLECULAR GENETICS

OXFORD UNIV PRESS

Lugar: Oxford; Año: 2023

0964-6906

Growth hormone (GH) binding to GH receptor activates janus kinase 2 (JAK2)-signal transducer and activator of transcription 5b (STAT5b) pathway which stimulates transcription of IGF1, IGFBP3, and IGFALS. Although STAT5B deficiency was established as an autosomal recessive disorder, heterozygous dominant-negative STAT5B variants have been reported in patients with less severe growth deficit and milder immune dysfunction. We developed an in vivo functional assay in zebrafish to characterize the pathogenicity of three human STAT5B variants (p.Ala630Pro, p.Gln474Arg, and p.Lys632Asn). Overexpression of human wildtype (WT) STAT5B mRNA and its variants led to a significant reduction of body length together with developmental malformations in zebrafish embryos. Overexpression of p.Ala630Pro, p.Gln474Arg or p.Lys632Asn led to an increased number of embryos with pericardial edema, cyclopia, and bent spine compared with WT STAT5B. While co-injection of WT and p.Gln474Arg and WT and p.Lys632Asn STAT5B mRNA in zebrafish embryos partially or fully rescues the length and the developmental malformations in zebrafish embryos, co-injection of WT and p.Ala630Pro STAT5B mRNA leads to a greater number of embryos with developmental malformations and a reduction in body length of these embryos. These results suggest that these variants could interfere with endogenous stat5.1 signaling through different mechanisms. In situ hybridization of zebrafish embryos overexpressing p.Gln474Arg and p.Lys632Asn STAT5B mRNA shows a reduction in igf1 expression.